The impressive clinical efficacy in both weight loss and diabetes management is a primary driver
Only 34% of GLP-1 patients on DPP-4 inhibitors, a class of oral diabetic medications also known as gliptins, were still taking DPP-4 inhibitors 52 weeks after starting GLP-1 therapy according to Earnest pharmacy claims data
H., Pagotto, U., & Ryan, D
Cost Comparison: Real 2026 Numbers A patient paying cash for Zepbound will pay roughly $15,000 per year at pharmacy retail, or about $5,400 per year at LillyDirects $449 self-pay maintenance rate
You can improve your sleep by focusing on healthy sleep hygiene habits
As the skin regenerates, it becomes smoother, even textured and hydrated